Renal cell carcinoma other imaging findings: Difference between revisions
Mahshid |
Farima Kahe (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{CMG}} | {{CMG}} {{AE}} {{F.K}} | ||
{{Renal cell carcinoma}} | {{Renal cell carcinoma}} | ||
==PET CT== | ==PET CT== | ||
The use of PET CT is not currently used as a standard for the diagnosis or follow-up in renal cell carcinoma, according to the 2013 American Urological Association guidelines.<ref name="pmid23665399">{{cite journal|author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.|title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399|doi=10.1016/j.juro.2013.04.121 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }}</ref> However, its use and advantages are still under investigation.<ref name="pmid23665399">{{cite journal|author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.|title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399|doi=10.1016/j.juro.2013.04.121 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }}</ref> | The use of PET CT is not currently used as a standard for the diagnosis or follow-up in renal cell carcinoma, according to the 2013 American Urological Association guidelines.<ref name="pmid23665399">{{cite journal|author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.|title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399|doi=10.1016/j.juro.2013.04.121 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }}</ref> However, its use and advantages are still under investigation.<ref name="pmid23665399">{{cite journal|author=Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH et al.|title=Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline. | journal=J Urol | year= 2013 | volume= 190 | issue= 2 | pages= 407-16 | pmid=23665399|doi=10.1016/j.juro.2013.04.121 | pmc=|url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23665399 }}</ref> | ||
Revision as of 15:32, 27 July 2018
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
|
Renal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Renal cell carcinoma other imaging findings On the Web |
|
American Roentgen Ray Society Images of Renal cell carcinoma other imaging findings |
|
Risk calculators and risk factors for Renal cell carcinoma other imaging findings |
PET CT
The use of PET CT is not currently used as a standard for the diagnosis or follow-up in renal cell carcinoma, according to the 2013 American Urological Association guidelines.[1] However, its use and advantages are still under investigation.[1]
Bone Scan
Bone scan is recommended in patients with elevated alkaline phosphatase (ALP) to rule out bone metastasis.[1]
Arteriography
Arteriography is not recommended anymore in renal cell carcinoma diagnosis or follow-up
References
- ↑ 1.0 1.1 1.2 Donat SM, Diaz M, Bishoff JT, Coleman JA, Dahm P, Derweesh IH; et al. (2013). "Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline". J Urol. 190 (2): 407–16. doi:10.1016/j.juro.2013.04.121. PMID 23665399.